Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 100

Results For "report"

1830 News Found

Mobile addicted generation heading towards hearing disorders: Survey
News | August 16, 2023

Mobile addicted generation heading towards hearing disorders: Survey

The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group


Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr
News | August 13, 2023

Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr

Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023


Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
News | August 13, 2023

Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr

Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023


Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr
News | August 12, 2023

Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr

Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023


IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr
News | August 12, 2023

IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr

IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023


Dimensionless Technologies launches AushadhAI to support pharma supply chain
Digitisation | August 12, 2023

Dimensionless Technologies launches AushadhAI to support pharma supply chain

AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents


SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr
News | August 10, 2023

SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr

The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023


Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr
News | August 10, 2023

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr

Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023


Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr
News | August 10, 2023

Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr

Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023


Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr
News | August 10, 2023

Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr

Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023